Leslie Jacobsen, M.D., Senior Vice President, Clinical Development
Dr. Jacobsen, M.D., is a highly accomplished pediatric and adult psychiatrist whose initial career in academic medicine focused on application of cognitive and neuroimaging probes in NIH funded studies of neuropsychiatric disease. Over her subsequent 13+ years in industry, Dr. Jacobsen has led teams working on all phases of clinical development, in neuroscience and in rare neuromuscular and lysosomal disease indications. She joins us most recently from AVROBIO, where she led the development of ex-vivo lentiviral gene therapies for the treatment of Gaucher disease and Cystinosis. Prior to AVROBIO, she held varying roles at Shire, Bristol-Myers Squibb, and Pfizer, working on all phases of clinical development, rare disease and neuroscience. Leslie earned her medical degree from Yale University School of Medicine, served as a Staff Fellow at the Child Psychiatry Branch at the National Institutes of Health, and was an Associate Professor of Psychiatry and Child Study at Yale School of Medicine prior to transitioning to the pharmaceutical industry.